ArticleBMJ open2025

Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mutant, grade 2/3 glioma.

Kristen McParland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.